CEO Phillip Chan Buys $105K in Open Market Amidst Delisting Threat and Going Concern Warning
CTSO sits 22% above its 52-week low of $0.37 on elevated volume (1.9× avg).
Summary
Cytosorbents CEO Phillip P. Chan purchased $104,898 of company stock in the open market, signaling confidence despite recent going concern warnings and a Nasdaq delisting threat.
Key Events · Ownership and Investor Activity · CTSO
-
CEO Open Market Purchase
Phillip P. Chan, CEO and Director, acquired 261,469 shares of common stock in two open market transactions between June 12 and June 15, 2026.
-
Significant Investment Value
The total value of the CEO's purchase was $104,898, representing a substantial personal investment for a company of this size.
-
Context of Financial Distress
This purchase occurs shortly after the company disclosed a going concern warning, received a Nasdaq delisting notice, and proposed a reverse stock split to shareholders.
Analysis · CTSO · Industrial Applications And Services
Cytosorbents' CEO, Phillip P. Chan, made a significant open market purchase of over $100,000 in company stock. This transaction is particularly notable given the company's recent disclosures, including a going concern warning, a Nasdaq delisting notice, and a proposed reverse stock split. The CEO's personal investment signals strong conviction in the company's future despite severe financial and operational challenges.
How filings like this one have moved
In the 30 days to Oct 21, 2026, 37.2% of the 999 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.80%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CTSO was trading at $0.45 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $27.1M. The 52-week trading range was $0.37 to $1.39. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.